Uniphar (UPR.I, UPR ID)
Uniphar is a diversified healthcare services business operating across three divisions: Commercial & Clinical (47% of group EBITDA 2022E), Product Access (19%) and Supply Chain & Retail (34%). Structural industry growth, proprietary digital platforms and expansion into new geographies underpin a strong organic growth outlook. There is also meaningful scope for bolt-on M&A, supported by a senior leadership team with deep experience across the healthcare services space. Management aims to double group EBITDA within five years (15% CAGR).
|Allianz Global Investors||9.0|
|Polar Capital LLP||7.4|
|Mackenzie Investments Europe Ltd.||2.8|
|Swedbank Robur Fonder AB||2.6|